Azim Karim in Houston, Texas

Medical School: Baylor College Of Medicine
Graduation Year: 2011
The Primary Medical Specialty for Azim Karim is listed as: General Practice
Approximate Years of Experience: 13
PAC (PECOS ID)#: 0345567269
NPI #: 1407119076
NPI Created On: 06/19/2012
NPI Last Updated Listed as: 03/12/2015
Primary Taxonomy Code: 208600000X
License Number:
BP10044092
Listed Gender: Male

Forms of insurance accepted by include, but are not limited to:

• Humana
• Blue Cross Blue Shield
• Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English, Urdu, Spanish, Hindi.

Services and Procedures include:

1. Testing for presence of drug
2. Urinalysis for bacteria
3. Vitamin d-3 level
4. Testosterone (hormone) level
5. Thyroxine (thyroid chemical) measurement
6. Blood test, thyroid stimulating hormone (tsh)
7. Ia nfct ab sarscov2 covid19
8. Measurement and recording of brain wave (eeg) activity, awake and drowsy
9. Testing of autonomic (sympathetic) nervous system function
10. Testing of autonomic (sympathetic) nervous system function
11. Application of electrical stimulation to 1 or more areas, each 15 minutes
12. Therapeutic exercise to develop strength, endurance, range of motion, and flexibility, each 15 minutes
13. Manual (physical) therapy techniques to 1 or more regions, each 15 minutes
14. Evaluation of physical therapy, typically 30 minutes
15. New patient office or other outpatient visit, typically 45 minutes
16. Established patient office or other outpatient visit, typically 15 minutes
17. Established patient office or other outpatient, visit typically 25 minutes
18. Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms
19. Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r